Stephanie Smith

Comparing the severity of chronic rhinosinusitis symptoms before versus during the COVID‐19 pandemic

A. Peters, B. Tan, D. Conley, 2022, Laryngoscope investigative otolaryngology.

Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps

A. Peters, T. Himi, A. Kato, 2019, Mucosal Immunology.

Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial

A. Peters, A. Kato, R. Schleimer, 2022, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

TNF Induces the Production of Type 2 Cytokines in Human Group 2 Innate Lymphoid Cells: 3

A. Peters, T. Himi, A. Kato, 2019, Journal of Allergy and Clinical Immunology.

Climate change, the environment, and rhinologic disease

B. Zaitchik, F. Baroody, D. Waugh, 2022, International forum of allergy & rhinology.

Is there a Role for Antibiotics in the Treatment of Chronic Rhinosinusitis?

R. Douglas, Raymond J T Kim, Stephanie Smith, 2022, The Journal of allergy and clinical immunology.

Retinoic acid promotes fibrinolysis and may regulate polyp formation.

S. Fujieda, T. Homma, A. Kato, 2022, Journal of Allergy and Clinical Immunology.

Prognostic Factors for Polyp Recurrence in Chronic Rhinosinusitis with Nasal Polyps.

A. Kato, R. Schleimer, B. Tan, 2022, The Journal of allergy and clinical immunology.

TNF induces the production of type 2 cytokines in human group 2 innate lymphoid cells.

T. Himi, A. Kato, R. Schleimer, 2019, The Journal of allergy and clinical immunology.